NEW YORK (GenomeWeb News) – Fluidigm today said it has closed on its public offering of 4,209,000 shares of its common stock and raised $56.1 million in net proceeds.

The South San Francisco, Calif.-based firm announced the offering last week and priced its shares at $14.25. It plans to use proceeds for R&D, commercialization efforts, working capital, and other general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.